Bosh sahifa539523 • BOM
add
Alkem Laboratories Ltd
Yopilish kursi
4 723,95 ₹
Kunlik diapazon
4 609,50 ₹ - 4 752,90 ₹
Yillik diapazon
4 409,90 ₹ - 6 440,00 ₹
Bozor kapitalizatsiyasi
553,45 mlrd INR
Oʻrtacha hajm
3,59 ming
Narx/foyda
25,73
Dividend daromadliligi
0,91%
Asosiy maydon
NSE
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(INR) | dek, 2024info | Y/Y qiyosi |
---|---|---|
Daromad | 33,74 mlrd | 1,52% |
Joriy xarajat | 14,96 mlrd | 8,29% |
Sof foyda | 6,26 mlrd | 5,19% |
Sof foyda marjasi | 18,55 | 3,63% |
Har bir ulushga tushum | 52,34 | -2,59% |
EBITDA | 7,39 mlrd | 4,74% |
Amaldagi soliq stavkasi | 12,35% | — |
Balans
Jami aktivlari
Jami passivlari
(INR) | dek, 2024info | Y/Y qiyosi |
---|---|---|
Naqd pul va qisqa investitsiyalar | 22,89 mlrd | -36,59% |
Jami aktivlari | — | — |
Jami passivlari | — | — |
Umumiy kapital | 119,10 mlrd | — |
Tarqatilgan aksiyalar | 119,57 mln | — |
Narxi/balansdagi bahosi | 4,91 | — |
Aktivlardan daromad | — | — |
Kapitaldan daromad | 12,59% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
(INR) | dek, 2024info | Y/Y qiyosi |
---|---|---|
Sof foyda | 6,26 mlrd | 5,19% |
Operatsiyalardan naqd pul | — | — |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | — | — |
Boʻsh pul | — | — |
Haqida
Alkem Laboratories Limited is a leading Indian multinational pharmaceutical company headquartered in Mumbai, India. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets a diverse portfolio of pharmaceutical generics, formulations and nutraceuticals across India and global markets.
With over five decades of expertise in the pharmaceutical industry, Alkem's journey began with a vision to transform India's healthcare landscape. Today, the company has established its presence in over 40 countries, operating 19 state-of-the-art manufacturing facilities and driving innovation through a team of 500+ scientists. Backed by a robust portfolio of 800+ brands, Alkem continues to set industry benchmarks in research, development, and manufacturing excellence.
Alkem primarily focuses on developing medications for a wide range of therapeutic areas, including infectious diseases, gastrointestinal disorders, pain management, gynecological conditions, pediatrics, osteoporosis, arthritis, cardiovascular diseases, diabetes, and several other critical health concerns. Wikipedia
Tashkil etilgan
1973
Bosh ofis
Sayt
Xodimlar soni
17 432